Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 15, 2007

View Archived Issues

Targeting the hepatic phase of malaria infection proves effective in animal studies

Interim data from ragweed study of Tolamba

Antibacterial activity of Indonesian traditional remedy confirmed by Mayo Clinic researchers

New phase I trial investigates suicide gene therapy in pancreatic adenocarcinoma

Recent AstraZeneca patents describe novel therapeutic agents for thrombotic disorders

Recent AstraZeneca patent describes new treatment option for arrhythmia

Recent patents report novel contraceptives and therapeutic agents for sexual dysfunction

Orthovisc studied in osteoarthritis of the shoulder joint

Phase I/II study evaluates Neuprex in HSCT

MP-12 Rift Valley fever vaccine to be evaluated in phase II study

Seattle Genetics and Agensys to develop ADC therapies for cancer

Organon and AMC collaborate on novel therapy for rheumatoid arthritis

Epiphany completes license for KSHV

Fispemifene significantly increases testosterone in androgen-deficient men

Phase I study of VAS-203 cleared to begin in Germany

DelSite grants GelSite license to EndoBiologics for bacillary dysentery vaccine

Speedel studies new renin inhibitor SPP-1148 in phase I

Studies of Cleveland's Protectans 600 series reveal new stem cell discovery

Endoscopic ultrasound administration of TNFerade cleared for use in PACT trial

Voraxaze progress updated

International launch of Promus everolimus-eluting stent

Humanetics to begin phase I trials for BIO-300 for ARS

Forest completes acquisition of Cerexa

PBI-1402 studied in anemic patients with chronic kidney disease

Rotigotine transdermal patch reduces RLS symptoms in second phase III study

Swedish MPA approves Cipralex in OCD

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...